“Recent Advances in Monoclonal Antibodies Based Formulation Used in the Management of CRC”. Journal of Pharmaceutical Negative Results (October 6, 2022): 324–338. Accessed June 3, 2026. https://pnrjournal.com/index.php/home/article/view/1663.